Pharmaniaga seeks the right medicine


Pharmaniaga Bhd managing director Zulkifli Jaafar. — AZLINA ABDULLAH/The Star

IT’s been two years since Pharmaniaga Bhd slipped into Practice Note 17 (PN17) status.

Will the company’s regularisation plan – recently approved by Bursa Malaysia – be able to lift it out of its doldrums?

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , PN17 , Vaccine , Insulin , Healthcare , Biopharma

Next In Business News

Fresh growth opportunities open for MNCs
George Kent redeems RM132mil sukuk
Aemulus wins RM10.5mil order, marks debut in India
ICT Zone Asia secures RM24.5mil ICT hardware purchase order
FBM KLCI remains steady amid choppy trading
China's yuan edges down as dollar gains; investors watch Iran war talks
MTT Shipping and Logistics targets RM652.5mil IPO to fund fleet expansion
Trump's tariffs had little impact on GDP in 2025, but raised revenue, academic paper finds
Oil prices climb as investors reassess Middle East ceasefire prospects
Lynas to develop rare earths metal production plant in Vietnam

Others Also Read